Evidence map›Paper›PMID 33962651›Full record

ArticleGlobalization and health2021

COVID-19-related stigma and its sociodemographic correlates: a comparative study.

Yuan Yuan, Yan-Jie Zhao, Qing-E Zhang, Ling Zhang, Teris Cheung, Todd Jackson, Guo-Qing Jiang, Yu-Tao Xiang

Open access · goldAbstract read
In one paragraph

Article in Globalization and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 3 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 3 syntheses or guidelines pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Yuan Yuan *Chongqing Mental Health Center, Chongqing, China.
Yan-Jie Zhao *Unit of Psychiatry, Department of Public Health and Medicinal Administration, & Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.ORCID 0000-0003-3989-9386
Qing-E Zhang *The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders Beijing Anding Hospital & the Advanced Innovation Center for Human Brain Protection, School of Mental Health, Capital Medical University, Beijing, China.
Ling Zhang *The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders Beijing Anding Hospital & the Advanced Innovation Center for Human Brain Protection, School of Mental Health, Capital Medical University, Beijing, China.
Teris CheungSchool of Nursing, Hong Kong Polytechnic University, Hong Kong SAR, China.
Todd JacksonDepartment of Psychology, University of Macau, Taipa, Macau SAR, China.
Guo-Qing JiangChongqing Mental Health Center, Chongqing, China. 1159424975@qq.com.
Yu-Tao XiangUnit of Psychiatry, Department of Public Health and Medicinal Administration, & Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China. xyutly@gmail.com.
University of Macau · MOCapital Medical University · CNChongqing City Mental Health Center · CNHong Kong Polytechnic University · HK

Funding

Beijing Municipal Science & Technology Commission No. Z181100001518005National Major Science and Technology Projects of China 2018ZX09201-014University of Macau MYRG2019-00066-FHS
6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) is closely associated with physical and mental health problems; however, little is known about the severity of stigma caused by COVID-19 among its survivors. Thus, the aim of this study was to compare differences in stigma experiences of COVID-19 survivors versus healthy controls after the COVID-19 outbreak peak in China.

methodsThis cross-sectional study comprised 154 COVID-19 survivors and 194 healthy controls recruited through consecutive and convenience sampling methods, respectively. COVID-19 related stigma was measured by the Social Impact Scale (SIS). Stigma differences between the two groups were compared with analysis of covariance (ANCOVA) and a generalized linear model (GLM) was used to identify independent correlates of COVID-19-related stigma in this study.

resultsCompared with healthy controls, COVID-19 survivors reported more overall stigma (F

conclusionCOVID-19-related stigma is commonly experienced among COVID-19 survivors even though the outbreak has been well-contained in China. Routine assessment of stigma experiences should be conducted on COVID-19 survivors and appropriate psychological assistance, public education, and anti-stigma campaigns and policies should be enforced to reduce stigma within this vulnerable subpopulation.

Indexed as

Social StigmaSocioeconomic FactorsAdultAnalysis of VarianceChinaCorrelation of DataCOVID-19Cross-Sectional StudiesFemaleHumansMaleMiddle AgedPandemicsCOVID-19 survivorsStigma

Identifiers

PMID33962651
PMCPMC8103123
OpenAlexW3157686659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.